Northeast India’s Only English And Hindi Satellite News Channel
                       

Russia’s Sputnik V gets emergency use authorisation nod in India

Russia’s Sputnik V got approval from the Subject Expert Committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India. According to sources,

Russia’s Sputnik V got approval from the Subject Expert Committee (SEC) for Emergency Use Authorisation (EUA), making it the third Covid-19 vaccine to get clearance in India.

According to sources, the SEC approved Dr Reddy’s application for EUA to Sputnik V.

The decision comes after the Drugs Controller General of India (DCGI)’s SEC met today to take up Sputnik V application for EUA in India.

Dr Reddy’s Laboratories, last week sought the government’s approval for the vaccine to be used in India. The Russian Direct Investment Fund (RDIF) partnered with Dr Reddy’s in September 2020 to conduct clinical trials of Sputnik V in India.

DCGI had then sought additional data from drugmaker Dr Reddy’s Laboratories on its Sputnik V Covid-19 vaccine trial.

India is currently manufacturing two Covid-19 vaccines, — Serum Institute of India’s locally-made Oxford Covid-19 vaccine ‘Covishield’ and Bharat Biotech’s indigenously manufactured Covaxin.

On Sunday, government sources told ANI that by end of the third quarter of this year, India will be getting vaccines from five additional manufacturers.

“India currently has two Covid-19 vaccines being manufactured locally: Covishield and Covaxin, and we can expect five more vaccines by Q3 2021. These vaccines are Sputnik V vaccine (in collaboration with Dr. Reddy’s), Johnson & Johnson vaccine (in collaboration with Biological E), Novavax vaccine (in collaboration with Serum India), Zydus Cadila’s vaccine, and Bharat Biotech’s Intranasal Vaccine. Safety and efficacy are the Union government’s primary concerns while granting emergency use authorisation (EUA) to any Covid-19 vaccine in the country,” the sources had told ANI.

The Russian vaccine has an effectiveness of 91.6 per cent. Russia registered Sputnik V for public use in August, the first country to do so, though the approval came before the start of the large-scale trial in September.

The EUA of Sputnik V comes at a time when India is facing the second wave of Covid-19 pandemic with the number of new cases increasing each day.

First Published: 12th April, 2021 17:40 IST

COMMENTS

WE RECOMMEND

Banner
Hectic parleys on Naga issue in next few days; CM Rio to visit Delhi

Neiba Kronu said that the panel will now meet the NSCN-IM leadership before May 31st.

25th May 2022
Banner
Mizoram Guv inaugurates 100th Electric Veng branch of MRB

The Mizoram Rural Bank also has the highest productivity per Branch among all the Regional Rural Banks in the country.

25th May 2022
Banner
Tripura police seize contraband worth Rs 5 lakh

Police found 78.5 grams of suspected brown sugar concealed inside six soap cases hidden in the vehicle’s handbrake cover.

25th May 2022
Banner
Mizoram: Congress’ H Malvina becomes new CEM of MADC

Meanwhile, Mizoram BJP has emerged as the single largest party in the MADC elections winning 12 seats.

25th May 2022
Banner
Guwahati: Suicide note of George Bordoloi sent for forensic tests

DCP said that the police are awaiting the forensic report after which they would take the next course of action.

25th May 2022